Arrow Financial Corp Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Arrow Financial Corp lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,326 shares of the healthcare conglomerate's stock after selling 3,250 shares during the quarter. Arrow Financial Corp's holdings in UnitedHealth Group were worth $2,266,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in UNH. Citizens National Bank Trust Department boosted its holdings in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its holdings in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after buying an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC bought a new position in shares of UnitedHealth Group in the 4th quarter worth about $515,000. Full Sail Capital LLC raised its position in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after acquiring an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $39,413,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer owned 203,796 shares in the company, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer owned 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $11.08 during midday trading on Thursday, reaching $281.43. The company's stock had a trading volume of 13,691,191 shares, compared to its average volume of 11,253,838. The firm has a market capitalization of $255.30 billion, a PE ratio of 11.77, a P/E/G ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a fifty day moving average of $301.70 and a 200 day moving average of $428.82. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.14%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent research reports. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a report on Friday, June 20th. Oppenheimer dropped their price objective on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. TD Securities reissued a "hold" rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Hsbc Global Res cut shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $394.43.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.